在新选项卡中打开链接
  1. Swedish Orphan Biovitrum - Wikipedia

    • Sobi is an international specialty healthcare company dedicated to rare diseases with a focus on treatments in haematology, immunology and speciality care. In 2013, Sobi had total revenues of SEK 2.2 billion (€253 M) and about 550 employees; by 2020 the revenue was SEK 15.261 billion and there were 1,509 employees. The share is listed at Nasdaq Stockholm: … 展开

    Overview

    Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to … 展开

    History

    Sobi traces its origins to a subsidiary of Kärnbolaget Aktiebolag Biokemisk Industri in the 1930s, which changed its name to Kabi [sv] in 1951 and merged with Vitrum [sv] to become KabiVitrum in the 1970s.
    Sobi has been in… 展开

    Acquisitions and licenses

    Synagis (From Astrazeneca) Dova Pharmaceuticals 展开

     
  1. 基于二阶盲辨识的盲源分离算法(SOBI算法)公式详细推导_盲识别算 …

  2. 独立成分分析(Independent Component Analysis)中 …

  3. 今日,IL-1受体拮抗剂在中国获批,治疗家族性地中海热

  4. 苏庇医药IL-1受体拮抗剂在中国获批新适应症 - 网易

  5. 今日,IL-1受体拮抗剂在中国获批,治疗家族性地中海热医药新闻-B…

  6. Sobi and Apellis enter collaboration for global co-development …

  7. 瑞典综合性生物技术公司:Swedish Orphan Biovitrum AB(BIOVF)

  8. Pipeline - Sobi

  9. 苏庇医药(上海)有限公司

  10. 某些结果已被删除